Cleveland Cavaliers fans are going to have to wait a bit longer until Max Strus makes his debut. Strus suffered a Jones’ fracture in his foot during the offseason and has yet to suit up for the ...

Your favorite latte at the local coffee shop could soon cost $5, $5.10 or $5.25—depending on how you pay. A settlement between Visa, Mastercard and U.S. merchants announced this week could usher in a ...

50 Cent didn’t miss the chance to stir the pot. On early Monday morning, Fif took to Instagram, using Max B’s recent prison release to troll Jim Jones. 50 posted a still from Belly, which shows the ...

There are a few ways to get AppleCare repair coverage even if the device is past the 60-day purchase window. Bridget Carey is an award-winning reporter who helps you level-up your life -- while having ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

A majority (68%) of small businesses have integrated AI into their daily operations, with 74% of them reporting an increase in productivity. Generative AI simplifies content creation while agentic AI ...

This is Java client for Max Bot API. It gives you full access to API in your Java code. Library has been built based on Max Bot API Schema that is OpenAPI-compliant. Full documentation of API can be ...

Company shares partnership and clinical updates including $7 million Sanofi milestone and more information on patient populations for REC-1245 (RBM39) and REC-617 (CDK7) SALT LAKE CITY, Aug. 05, 2025 ...

Officially, Microsoft will stop providing new security updates for Windows 10 PCs after October 14, 2025, a little over a decade after its initial release. It's a stick that Microsoft is using to push ...

HBO Max has added one of the best horror movies of all time. How long the horror movie is going to be streaming free with HBO Max remains to be seen, but it is part of the July 2025 lineup. And it is ...

Recursion's AI-enabled drug discovery platform continues to evolve, but this is yet to translate into meaningful clinical success. The recent cull of programs has further undermined investor ...